Vlp Therapeutics

Developer of therapeutic vaccines for the treatment of cancer, infectious and CNS disease

placeGaithersburg, Maryland, United States calendar_todayFounded 2012 groups15 employees language vlptherapeutics.com

Innovation

15 patent families (10 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,055 times.

YearFilings
20154
20166
20178
20183
20195
20205
20215
20227
20236
20243
20256
20261

Investor mix

15 investors on record; lead investors include Toyo Ink Group, Miyako Capital, Sojitz, Konishiyasu.

Investor typeCountShare
Venture capital533%
Accelerator & incubator17%
Bank & private debt17%
Other / undisclosed853%
Coming soon